These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28502234)

  • 1. A gonadotropin-releasing hormone agonist for the prevention of docetaxel-induced gonadal damage.
    Park I; Lee S; Ryu KJ; Min KJ; Hong JH; Song JY; Lee JK; Lee NW
    J Obstet Gynaecol; 2017 Aug; 37(6):783-789. PubMed ID: 28502234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
    Bildik G; Akin N; Senbabaoglu F; Sahin GN; Karahuseyinoglu S; Ince U; Taskiran C; Selek U; Yakin K; Guzel Y; Ayhan C; Alper E; Cetiner M; Balaban B; Mandel NM; Esen T; Iwase A; Urman B; Oktem O
    Hum Reprod; 2015 Dec; 30(12):2912-25. PubMed ID: 26466909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist.
    Ozcelik B; Turkyilmaz C; Ozgun MT; Serin IS; Batukan C; Ozdamar S; Ozturk A
    Fertil Steril; 2010 Mar; 93(5):1609-14. PubMed ID: 19339002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
    Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists.
    Danforth DR; Arbogast LK; Friedman CI
    Fertil Steril; 2005 May; 83(5):1333-8. PubMed ID: 15866565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?
    Hasky N; Uri-Belapolsky S; Goldberg K; Miller I; Grossman H; Stemmer SM; Ben-Aharon I; Shalgi R
    Hum Reprod; 2015 May; 30(5):1089-101. PubMed ID: 25796551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of a gonadotropin-releasing hormone analogue on chemotherapeutic agent-induced ovarian gonadotoxicity: a mouse model.
    Tan SJ; Yeh YC; Shang WJ; Wu GJ; Liu JY; Chen CH
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):182-5. PubMed ID: 20074846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of GnRH analogs on the expression of Bcl-2 gene family in the ovary of rats with cyclophosphamide-induced ovarian damage].
    Peng P; Yang DZ; Yang CH; Zhang W; Zhang YL; Liu J; Ye CL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):2014-7. PubMed ID: 19033116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of cyclophosphamide-induced ovarian damage by concomitant administration of GnRHa in mice: a dose-dependent relationship?
    Yüce MA; Balkanli Kaplan P; Gücer F; Doğanay L; Altaner S; Canda T; Yardim T
    Eur J Gynaecol Oncol; 2004; 25(5):628-31. PubMed ID: 15493183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the prevention of chemotherapy-induced ovarian damage by gonadotropin-releasing hormone agonist in rat model].
    Yuan GW; Shen K; Yang JX
    Zhonghua Fu Chan Ke Za Zhi; 2005 Oct; 40(10):666-9. PubMed ID: 16277895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of the protective effect of gonadotropin-releasing hormone agonist and antagonist on bleomycin-induced ovarian toxicity in rats.
    Atakul T; Tayyar AT; Turan ÖD; Çelik SY; Yılmaz M; Küçük M; Yüksel H; Demirci B
    Gynecol Endocrinol; 2021 Jan; 37(1):46-50. PubMed ID: 32283955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of gonadotropin-releasing hormone agonist on the effect of chemotherapy upon ovarian cancer and the prevention of chemotherapy-induced ovarian damage: an experimental study with nu/nu athymic mice.
    Lin QY; Wang YF; Weng HN; Sheng XJ; Jiang QP; Yang ZY
    J Zhejiang Univ Sci B; 2012 Nov; 13(11):894-903. PubMed ID: 23125082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GNRH agonists and antagonists in rescue for cyclophosphamide-induced ovarian damage: friend or foe?
    Parlakgumus HA; Kilicdag EB; Bolat FA; Haydardedeoglu B; Parlakgumus A
    Arch Gynecol Obstet; 2015 Jun; 291(6):1403-10. PubMed ID: 25472738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GnRH agonist acts as ovarian protection in chemotherapy induced gonadotoxicity: an experiment using a rat model.
    Matsuo G; Ushijima K; Shinagawa A; Takahashi S; Fujiyoshi N; Takemoto S; Terada A; Fukui A; Kamura T
    Kurume Med J; 2007; 54(1-2):25-9. PubMed ID: 18332593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the effects of gonadotropin-releasing hormone analogues in the inhibition of ovarian cancer transplanted tumors and in the protection of ovarian function after chemotherapy on nude mice].
    Zhang Y; Lu ZY; Yan XH; Wang JJ; Feng WW; Ding JX; Hua Kq
    Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):892-7. PubMed ID: 22333277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GnRH antagonist reduces chemotherapy-induced ovarian damage in rats by suppressing the apoptosis.
    Huang YH; Zhao XJ; Zhang QH; Xin XY
    Gynecol Oncol; 2009 Feb; 112(2):409-14. PubMed ID: 19038435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries.
    Blumenfeld Z
    Oncologist; 2007 Sep; 12(9):1044-54. PubMed ID: 17914074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a gonadotropin-releasing hormone analogue on cyclophosphamide-induced ovarian toxicity in adult mice.
    Kishk EA; Mohammed Ali MH
    Arch Gynecol Obstet; 2013 May; 287(5):1023-9. PubMed ID: 23224696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.